Aisthesis Medical Secures $1.2M for AI Sepsis Prediction Platform
Aisthesis Medical has announced the successful closing of a $1.2 million pre-seed funding round. The funding, led by Twin Path Ventures with participation from TECS Capital, will be used to accelerate the development and regulatory clearance of VIOSync SPI, an AI-powered clinical decision support platform.
VIOSync SPI is designed to predict the onset of sepsis within the next 48 hours by securely ingesting multimodal patient data from hospital systems. This platform aims to provide clinicians with actionable insights to intervene earlier and potentially save lives. The investment will support the advancement of CE MDR submission for VIOSync SPI and expand clinical validation studies across leading hospitals in the UK and EU.
The funding will also enable Aisthesis Medical to strengthen its team and prepare for NHS and international pilot deployments, furthering its mission to empower clinicians with trusted AI tools for preventing life-threatening conditions.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AI Nov 19 Boltz raises $110 million to build AI models for drug designMore from Funding
Nov 20 hackajob raises $10 million to expand Archer, its AI recruiting agent Nov 20 Protesters rally against Anthropic in New York and San Francisco on its stock market debut Nov 19 Anthropic's IPO could channel about $156 billion to charity, TechCrunch estimates Nov 19 Sierra reportedly in talks to raise at a $30 billion valuation Nov 19 Everful raises $48.5 million to build AI infrastructure for global commerceAI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Ailytics Raises $7.4 Million for Visual AI Expansion
Pathos AI Raises $237 Million at $3 Billion Valuation
Mosaic Raises $47M for Blood Vessel Surgery Robots
Atlas Bio raises $12.5 million for virtual drug trials
BioStack Raises $9.5 Million for Medical AI Data Network
Daily AI Brief: the AI news that matters, in your inbox.